Ximluci Uniunea Europeană - română - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Citramon-Pharmstandard 240 mg/180 mg/30 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

citramon-pharmstandard 240 mg/180 mg/30 mg comprimate

farmstandart-leksredstva sad - acid acetylsalicylicum + paracetamolum + cofeina - comprimate - 240 mg/180 mg/30 mg